A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biochemical Pharmacology

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.bcp.2010.08.016PMID 20804740PMCID PMC2958249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aryl Hydrocarbon Receptor Is a Transcriptional Activator of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

  2010cited by this paper
• The drug transporter-metabolism alliance: uncovering and defining the interplay.

  2009cited by this paper
• Introducing the "TCDD-inducible AhR-Nrf2 gene battery".

  2009cited by this paper
• Bioactive Terpenoids and Flavonoids from Ginkgo Biloba Extract Induce the Expression of Hepatic Drug-Metabolizing Enzymes Through Pregnane X Receptor, Constitutive Androstane Receptor, and Aryl hydrocarbon Receptor-Mediated Pathways

  2009cited by this paper
• Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene.

  2008cited by this paper
• The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2)

  2007cited by this paper
• Peroxisome Proliferator-activated Receptor γ-regulated ABCG2 Expression Confers Cytoprotection to Human Dendritic Cells*

  2006cited by this paper
• Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.

  2006cited by this paper
• Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes

  2006cited by this paper
• Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate.

  2006influential reference
• Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells.

  2006cited by this paper
• Deconvoluting the effects of P-glycoprotein on intestinal CYP3A: a major challenge.

  2006cited by this paper
• Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists.

  2005cited by this paper
• Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps

  2005cited by this paper
• Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.

  2005cited by this paper
• Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells.

  2005cited by this paper
• Identification of a Novel Estrogen Response Element in the Breast Cancer Resistance Protein (ABCG2) Gene

  2004cited by this paper
• The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme*

  2004cited by this paper
• Involvement of the Xenobiotic Response Element (XRE) in Ah Receptor-mediated Induction of Human UDP-glucuronosyltransferase 1A1 *

  2003cited by this paper
• Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor

  2003cited by this paper
• Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.

  2003cited by this paper
• Multidrug resistance and cancer: the role of the human ABC transporter ABCG2.

  2002cited by this paper
• ABC Transporters as Phenotypic Markers and Functional Regulators of Stem Cells

  2002cited by this paper
• Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.

  2002cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper
• Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene.

  2001cited by this paper
• The phenobarbital response enhancer module in the human bilirubin UDP‐glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR

  2001cited by this paper
• Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

  2001cited by this paper
• The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1.

  2000cited by this paper
• Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity.

  1999cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor.

  1998cited by this paper
• Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin.

  1998cited by this paper
• Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor.

  1997cited by this paper
• The aryl hydrocarbon receptor complex.

  1995cited by this paper
• Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene.

  1993cited by this paper
• Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor.

  1992cited by this paper

• Gut Microbiota in the Regulation of Intestinal Drug Transporters: Molecular Mechanisms and Pharmacokinetic Implications

  2025cites this paper
• Personalized statin therapy: Targeting metabolic processes to modulate the therapeutic and adverse effects of statins

  2025cites this paper
• Cigarette smoke-induced attenuation of the prostaglandin transporter SLCO2A1 expression through aryl hydrocarbon receptor.

  2024cites this paper
• Discovery and optimisation of pyrazolo[1,5-a]pyrimidines as aryl hydrocarbon receptor antagonists.

  2024cites this paper
• Combination screen in multi-cell type tumor spheroids reveals interaction between aryl hydrocarbon receptor antagonists and E1 ubiquitin-activating enzyme inhibitor: Aryl-hydrocarbon receptor antagonist drug combinations.

  2024cites this paper
• Induction of drug metabolizing enzyme and drug transporter expression by antifungal triazole pesticides in human HepaSH hepatocytes.

  2024cites this paper
• Efflux transporters in drug disposition during pregnancy.

  2024cites this paper
• Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs

  2024cites this paper
• Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.

  2023cites this paper
• Promotion of ABCG2 gene expression by neolignans from Piper longum L.

  2023cites this paper
• New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells

  2023cites this paper
• Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.

  2022cites this paper
• An overview of aryl hydrocarbon receptor ligands in the Last two decades (2002-2022): A medicinal chemistry perspective.

  2022cites this paper
• Multidrug efflux transporter ABCG2: expression and regulation

  2021cites this paper
• The ABCG2/BCRP transporter and its variants – from structure to pathology

  2020cites this paper
• Low oxygen tension differentially regulates the expression of placental solute carriers and ABC transporters

  2020cites this paper
• Precision-engineered reporter cell lines reveal ABCG2 regulation in live lung cancer cells.

  2020cites this paper
• Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species

  2020cites this paper
• Bile duct obstruction leads to increased intestinal expression of breast cancer resistance protein with reduced gastrointestinal absorption of imatinib.

  2019cites this paper
• Modulation of ABC Transporters by Nuclear Receptors: Physiological, Pathological and Pharmacological Aspects.

  2019cites this paper
• Cellular Processing of the ABCG2 Transporter—Potential Effects on Gout and Drug Metabolism

  2019cites this paper
• Additional Prognostic Markers of Human Colon Adenocarcinoma

  2019cites this paper
• Pharmacologic inducers of the uric acid exporter ABCG2 as potential drugs for treatment of gouty arthritis

  2019cites this paper
• Environmental pollutants-dependent molecular pathways and carcinogenesis

  2019cites this paper
• Additional Prognostic Markers of Human Colon Adenocarcinoma

  2019cites this paper
• Interindividual Regulation of the Breast Cancer Resistance Protein/ABCG2 Transporter in Term Human Placentas

  2018influential citation
• Aryl-Hydrocarbon Receptor as a Potential Target for Anticancer Therapy

  2018cites this paper
• Aryl hydrocarbon receptor and intestinal immunity

  2018cites this paper
• Targeting the Genetic and Molecular Role of ABCG2 Following Traumatic Brain Injury

  2018cites this paper
• АНАЛИЗ ДОПОЛНИТЕЛЬНЫХ ПРОГНОСТИЧЕСКИХ МАРКЕРОВ АДЕНОКАРЦИНОМЫ ТОЛСТОЙ КИШКИ ЧЕЛОВЕКА, "Цитология"

  2018cites this paper
• Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts

  2017cites this paper
• Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling.

  2017influential citation
• Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target

  2017cites this paper
• Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP

  2017cites this paper
• Phytochemical mediated-modulation of the expression and transporter function of breast cancer resistance protein at the blood-brain barrier: An in-vitro study.

  2017cites this paper
• Exploration de l’impact de l’exposition chronique et faibles doses de facteurs environnementaux sur les cellules pré-cancéreuses mammaires MCF10AT1

  2017cites this paper
• Mechanisms of xenobiotic receptor activation: Direct vs. indirect.

  2016cites this paper
• Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate.

  2016cites this paper
• Phytochemical mediated modulation of breast cancer resistance protein at the blood brain barrier and blood cerebrospinal fluid barrier

  2016influential citation
• Transcriptional regulation of human and murine short-chain dehydrogenase/reductases (SDRs) – an in silico approach

  2016cites this paper
• Role of Breast Cancer Resistance Protein (BCRP, ABCG2) in Cancer Outcomes and Drug Resistance

  2015cites this paper
• Phytoestrogens Modulate Breast Cancer Resistance Protein Expression and Function at the Blood-Cerebrospinal Fluid Barrier.

  2015cites this paper
• Establishment of a stable aryl hydrocarbon receptor-responsive HepG2 cell line

  2015cites this paper
• Resistance to Targeted ABC Transporters in Cancer

  2015cites this paper
• The Role of ABC Multidrug Transporters in Resistance to Targeted Anticancer Kinase Inhibitors

  2015cites this paper
• Role of the Aryl Hydrocarbon Receptor in Colon Neoplasia

  2015cites this paper
• Régulation de l'expression fonctionnelle de transporteurs membranaires dans des cellules hépatocytaires et pulmonaires exposées aux extraits de particules diesel

  2015cites this paper
• Aryl hydrocarbon receptor regulates CYP1B1 but not ABCB1 and ABCG2 in hCMEC/D3 human cerebral microvascular endothelial cells after TCDD exposure.

  2015cites this paper
• The Role of Ahr in Anticancer Drug Resistance in Breast Cancer

  2015cites this paper
• Regulation of Human Hepatic Drug Transporter Activity and Expression by Diesel Exhaust Particle Extract

  2015cites this paper
• Homeostatic control of xeno- and endobiotics in the drug-metabolizing enzyme system.

  2014cites this paper
• Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics

  2014cites this paper
• 2,3,7,8-Tetrachlorodibenzo-P-Dioxin Induced Cell-Specific Drug Transporters With Acquired Cisplatin Resistance in Cisplatin Sensitive Cancer Cells

  2014cites this paper
• Breast Cancer Resistance Protein (BCRP) or ABCG2

  2014cites this paper
• Regulation of ABCG2 Expression in the Lactating Mammary Gland

  2014cites this paper
• Fungicide prochloraz and environmental pollutant dioxin induce the ABCG2 transporter in bovine mammary epithelial cells by the arylhydrocarbon receptor signaling pathway.

  2013cites this paper
• Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2.

  2013cites this paper
• Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.

  2013cites this paper
• 14. BCRP (ABCG2)

  2013cites this paper
• Molecularly-targeted anti-cancer drug interactions of the human ABCG2 multidrug transporter

  2013cites this paper
• [Transcriptional regulation of breast cancer resistance protein].

  2012cites this paper
• Pulmonary , gastrointestinal and urogenital pharmacology ABCB 1 ( P-glycoprotein ) reduces bacterial attachment to human gastrointestinal LS 174 T epithelial cells

  2012cites this paper
• Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

  2012cites this paper
• Polycyclic Aromatic Hydrocarbons (PAHs) Mediate Transcriptional Activation of the ATP Binding Cassette Transporter ABCB6 Gene via the Aryl Hydrocarbon Receptor (AhR)*

  2012cites this paper
• ABCB1 (P-glycoprotein) reduces bacterial attachment to human gastrointestinal LS174T epithelial cells.

  2012cites this paper
• Chinese a Nti鄄 Cancer a Ssociation

  2012cites this paper
• Stimulus-induced expression of the ABCG2 multidrug transporter in HepG2 hepatocarcinoma model cells involves the ERK1/2 cascade and alternative promoters.

  2012cites this paper
• Transactivation of ABCG2 through a novel cis-element in the distal promoter by constitutive androstane receptor but not pregnane X receptor in human hepatocytes.

  2012cites this paper
• Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.

  2012cites this paper
• Ah Receptor Antagonism Represses Head and Neck Tumor Cell Aggressive Phenotype

  2012cites this paper
• Specific inhibition of the ABCG2 transporter could improve the efficacy of photodynamic therapy.

  2011cites this paper
• Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier.

  2011cites this paper
• Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers.

  2011cites this paper
• 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation.

  2011cites this paper
• Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor.

  2011cites this paper
• Coffee induces breast cancer resistance protein expression in Caco-2 cells.

  2011cites this paper
• The expressions of ABCC4 and ABCG2 xenobiotic transporters in human keratinocytes are proliferation-related

  2011cites this paper
• Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?

  2011influential citation